key: cord-0790322-7jlqisy1 authors: Roshni, Jency; Vaishali, R; Ganesh, KS; Dharani, N; Alzahrani, Khalid J.; Banjer, Hamsa Jameel; Alghamdi, Ali H.; Theyab, Abdulrahman; Ahmed, Shiek SSJ; Patil, Shankargouda title: Multi-target potential of Indian phytochemicals against SARS-CoV-2: a docking, molecular dynamics and MM-GBSA approach extended to Omicron B.1.1.529. date: 2022-05-13 journal: J Infect Public Health DOI: 10.1016/j.jiph.2022.05.002 sha: d0def1a5141eebd8d0aa1ffbf7180ab79e2e7ee6 doc_id: 790322 cord_uid: 7jlqisy1 BACKGROUND: SARS-CoV-2, an emerged strain of corona virus family became almost serious health concern worldwide. Despite vaccines availability, reports suggest the occurrence of SARS-CoV-2 infection even in a vaccinated population. With frequent evolution and expected multiple COVID-19 waves, improved preventive, diagnostic, and treatment measures are required. In recent times, phytochemicals have gained attention due to their therapeutic characteristics and are suggested as alternative and complementary treatments for infectious diseases. This present study aimed to identify potential inhibitors against reported protein targets of SARS-CoV-2. METHODOLOGY: We computationally investigated potential SARS-CoV-2 protein targets from the literature and collected druggable phytochemicals from Indian Medicinal Plants, Phytochemistry and Therapeutics (IMPPAT) database. Further, we implemented a systematic workflow of molecular docking, dynamic simulations and generalized born surface area free-energy calculations (MM-GBSA). RESULTS: Extensive literature search and assessment of 1508 articles identifies 13 potential SARS-CoV-2 protein targets. We screened 501 druggable phytochemicals with proven biological activities. Analysis of 6513(501 *13) docked phytochemicals complex, 26 were efficient against SARS-CoV-2. Amongst, 4,8-dihydroxysesamin and arboreal from Gmelina arborea were ranked potential against most of the targets with binding energy ranging between -10.7 to -8.2 kcal/mol. Additionally, comparative docking with known drugs such as arbidol (-6.6 to -5.1 kcal/mol), favipiravir (-5.5 to -4.5 kcal/mol), hydroxychloroquine (-6.5 to -5.1 kcal/mol), and remedesivir (-8.0 to -5.3 kcal/mol) revealed equal/less affinity than 4,8-dihydroxysesamin and arboreal. Interestingly, the nucleocapsid target was found commonly inhibited by 4,8-dihydroxysesamin and arboreal. Molecular dynamic simulation and Molecular mechanics generalized born surface area (MM-GBSA)calculations reflect that both the compounds possess high inhibiting potential against SARS-CoV-2 including the recently emerged Omicron variant (B.1.1.529). CONCLUSION: Overall our study imparts the usage of phytochemicals as antiviral agents for SARS-CoV-2 infection. Additional in vitro and in vivo testing of these phytochemicals is required to confirm their potency. COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which leads to pneumonia (Renu et al. 2020 ) and multi-organ failure ( treatment has created an opportunity towards alternate therapy (Ahmad et al. 2021 The molecular affinity of phytochemicals bound to the protein targets have been analyzed. Among them, arboreal and 4,8-dihydroxysesamin from Gmelina arborea species showed significant affinity to most of the protein targets, than known drugs of SARS-CoV-2. A systematic literature search was carried out in PubMed/MEDLINE, Google Scholar, and preprint databases to identify studies reporting molecular targets for SARS-CoV-2 from 31 December 2019 (first reported case in Wuhan, China) to June 2021. Two authors (GK and DN) independently reviewed the titles and abstracts of the articles. Any duplicates in the collected articles were removed. Relevant abstracts were shortlisted and full-length papers were assessed for the eligibility by other three authors (JR and VR) and any disagreement was resolved by group discussion with the authors (SP and SSJ). The selection of article is based on inclusion and exclusion criteria. The inclusion criteria was the article reporting J o u r n a l P r e -p r o o f molecular targets of SARS-CoV-2 and the exclusion criteria were: 1) Studies that did not report molecular targets in SARS-CoV-2; and 2) Clinical, pre-clinical, incidence, prevalence studies, case or news reports. From the selected articles, following information were extracted such as the first author name, country, name of the molecular targets, (Protein Data Bank) PDB IDs, name of the ligands/compounds, and any accessible ligands/compounds IDs to retrieve the structures from databases. Based on the collected information, 13 proteins targets of SARS-CoV-2 were shortlisted. The three dimensional (3D) structures of 13 targets were retrieved from RCSB protein data bank in the PDB format. Each structure was cleaned by1) removing the water molecules, unwanted chains and co-crystallized ligands, 2) Adding missing hydrogens to the chains, 3) optimizing the H-bonds, and 4) applying force field to have stable conformation (Guex et al. 1997 ). Additionally, the homology modelling was performed by following the Dong et al., 2020 to generate nucleocapsid structure for SARS-CoV-2 Omicron variant (B.1.1.529) from the protein sequence retrieved from NCBI GenBank: (Accession no. UFO69287.1). Further the modelled structure was refined (Basu et al., 2020) for later assessment. The phytochemicals used in this study were collected from IMPPAT database (Mohanraj et al. 2018) . IMPPAT is publically accessible to download the compounds structure for virtual screening. Currently, IMPPAT has more than 9500 phytochemicals with biologically relevant information. Of 9500 available structures [Accessed on: July 2021], a set of phytochemicals were selected based on the druggable properties, which include Lipinski rule of five and Oral PhysChem score. Simultaneously, the structure of known drugs such as arbidol (131411), favipiravir (492405), hydroxychloroquine (3652), and remedesivir (121304016) were collected from the NCBI-PUBCHEM compound database. All selected molecules were imported to UCSF Chimera 1.14 for structural geometry optimization. The molecular docking was performed using Vina (Trott. phytochemicals showing least binding energy to each target was selected for further analysis. Among top-3 phytochemicals of each target, arboreal and 4,8-dihydroxysesamin were overrepresented against multiple targets. Of these targets, nucleocapsid was noticed to be inhibited by both arboreal and 4,8-dihydroxysesamin with high affinity. Following phytochemicals and target selection, MD simulations were performed using the GROMACS 2020.4 version for six nucleocapsid-ligand complexes that includes, two phytochemicals (arboreal and 4, 8-dihydroxysesamin) and four drugs (arbidol, favipiravir, hydroxychloroquine, and remedesivir). The simulations were performed for up to 10 ns for each complex system. The GROMOS54a7 and single-point charge (SPC) were implemented. The topologies files for the phytochemicals and the drugs were generated using PRODRG server. All the complexes were simulated inside the cubic box with ions neutralized. In energy minimization, steps of steepest decent method (n=5,000) was adopted to resolve bad contacts and clashes in the complexes. Following the energy minimization, NVT and NPT equilibration were performed. Further simulations were performed to assess random mean square deviation (RMSD) and root-mean-square fluctuation (RMSF) between the complexes based on time frame. Based on the literature search strategy described in the methodology section, 1508 relevant articles were retrieved for the initial phase of assessment. The authors determined that the titles and abstracts contained in 90 articles were worthy for full-text reading. Among which, J o u r n a l P r e -p r o o f inclusion/exclusion criteria. From the selected studies, SARS-CoV-2 protein targets such as Replicase polyprotein 1a, ADP ribose phosphatase of NSP3, E-protein, NSP16, NSP1, NSP15, NSP13 helicase, NSP12, spike glycoprotein, 3CL pro , PL pro , RNA-dependent RNA polymerase (RdRp), and nucleocapsid were collected. For each protein, the PDB structure was retrieved from the RCSB database using the PDB IDs mentioned in the articles. The appropriate protein structure, 6YHU (replicase polyprotein 1a), 6VXS (ADP ribose phosphatase of NSP3), 2MM4 6M3M (nucleocapsid) were taken from PDB using its Accession IDs. Each structure was processed to have stable conformation before molecular docking. Among the 9500 phytochemicals in IMPPAT database, 908 were identified as druggable compounds. These selected phytochemicals belong to more than 400 plant species of Indian origin. The characteristics of these phytochemicals were flavonoids, lipids, benzoxepines, naphthopyrans, coumarins, indolizidines and organooxygen compounds. Few of these phytochemicals were noticed common among the plants. After removing duplicates, a total of 501 phytochemicals were retained. For comparative analysis, the structure of known drugs such as arbidol, favipiravir, hydroxychloroquine, and remedesivir were collected. The structure of each molecule was retrieved in PDB format and processed as mentioned in methodology section. The hydroxychloroquine and remedesivir ( Fig. 1-2) . MD simulations were performed for the arboreal-nucleocapsid and 4,8-dihydroxysesamin-nucleocapsid complexes and compared with the four nucleocapsid-drug complexes. Six The MM-GBSA is one of the most popular methods to determine the binding affinity of Arboreal binds with nucleocapsid of SARS-CoV-2 (-10.6 kcal/mol) at GLY70, PRO163, GLN84, VAL73 and LEU162 residues (Fig.1A) . LEU162, three carbon hydrogen bonds with THR166, LEU162 and GLN161 (Fig. 1B) . Whereas, arbidol exhibit interaction with nucleocapsid at THR136, GLN164, GLY70, PRO163, ILE75 and PRO81 residues ( Fig. 2A) . Likewise, favipiravir (Fig. 2B) , and hydroxychloroquine (Fig. 2C ) interact with nucleocapsid with the binding energy between -5.2 to -4.5 kcal/mol. Remedesivir showed interactions with nucleocapsid at ASN76, GLU84, ILE75, PRO163, and PRO81 with binding energy(-5.3 kcal/mol) (Fig. 2D ). To date, several molecular docking studies were performed using phytochemicals (Table 1) . Furthermore, we have tried to explain the importance of our results using the nucleocapsid protein as a common target for both the phytochemicals with least binding energies. In conclusion, our molecular docking and dynamic simulation found that both J o u r n a l P r e -p r o o f Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage -A review COVID-19 and multiorgan failure: A narrative review on potential mechanisms Coronavirus biology and replication: implications for SARS-CoV-2 A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel Drug repurposing approach to fight COVID-19 Beneficial effect of Arbidol in the management of COVID-19 infection Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications Remdesivir for the Treatment of Covid-19 -Final Report Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19 Cardiac Adverse Events With Remdesivir in COVID-19 Infection Indian Medicinal Plants and Formulations and Their Potential Against COVID-19-Preclinical and Clinical Research Analysis of Inhibitor Binding Combined with Reactivity Studies to Discover the Potentially Inhibiting Phytochemicals Targeting Chikungunya Viral Replication Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24 In-silico screening for anti-Zika virus phytochemicals A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19 Complementary Intervention for COVID-19 A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19 Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2 A guideline for homology modeling of the proteins from newly discovered betacoronavirus IMPPAT: A curated database of Indian Medicinal Plants AutoDockVina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading Small-molecule library screening by docking with PyRx Intuitive, reproducible high-throughput molecular dynamics in Galaxy: a tutorial High performance molecular simulations through multi-level parallelism from laptops to supercomputers A hierarchical approach to all-atom protein loop prediction On the role of the crystal environment in determining protein side-chain conformations ACPYPE -AnteChamberPYthon Parser interfacE Bio3d: an R package for the comparative analysis of protein structures Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity Antiviral potentials of medicinal plants Herbal medicine: toxicity and recent trends in assessing their potential toxic effects Indian Ethnomedicinal Phytochemicals as Promising Inhibitors of RNA-Binding Domain of SARS-CoV-2 In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19 Phytochemicals from Selective Plants Have promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations Gmelina arborea-an indigenous timber species of India with high medicinal value: A review on its pharmacology, pharmacognosy and phytochemistry This study was not funded by any private or government organization. Authors from the four institutes declare that they have no competing interest.